These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2885048)

  • 1. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia.
    Kurzrock R; Kloetzer WS; Talpaz M; Blick M; Walters R; Arlinghaus RB; Gutterman JU
    Blood; 1987 Jul; 70(1):233-6. PubMed ID: 2885048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-abl in Philadelphia-positive acute myelogenous leukemia.
    Kurzrock R; Shtalrid M; Talpaz M; Kloetzer WS; Gutterman JU
    Blood; 1987 Nov; 70(5):1584-8. PubMed ID: 3311207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
    Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D
    Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
    Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
    Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in expression of the bcr-abl fusion transcript in CML blast crisis.
    Andrews DF; Collins SJ
    Leukemia; 1987 Oct; 1(10):718-24. PubMed ID: 3312834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration.
    Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON
    Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
    Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
    Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myelogenous leukemia: amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis.
    Collins SJ; Groudine MT
    Blood; 1987 Mar; 69(3):893-8. PubMed ID: 3545323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia stem cells.
    Jamieson CH
    Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
    Bartram CR
    Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural organization of the bcr gene and its role in the Ph' translocation.
    Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
    Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
    J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Philadelphia-positive chronic myeloid leukemia with a chromosome 22 breakpoint outside the breakpoint cluster region.
    Selleri L; Narni F; Emilia G; Colò A; Zucchini P; Venturelli D; Donelli A; Torelli U; Torelli G
    Blood; 1987 Nov; 70(5):1659-64. PubMed ID: 3478105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.